Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.116985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Mees Botman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam Cardiovascular Sciences Institute, Amsterda…. Hauptthemen laut MEDLINE: Interferon-gamma, Janus Kinase 1, Signal Transduction, STAT3 Transcription Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Corona Foundation, Netherlands Organisation for Health Research and Development.
Abstract (Originalsprache)
Interferon γ (IFN-γ) is a key cytokine in immune activation, especially anti-viral responses, and a driver of macrophage activation. It classically signals via JAK1/2-mediated STAT1 homodimers. Here, we identify an alternative, non-canonical signaling component in which IFN-γ simultaneously also activates STAT3. Our results show that IFN-γ activates STAT3 rapidly and directly through JAK1 and JAK2. We provide evidence that STAT3 can form heterodimers with STAT1 in this context and demonstrate that STAT3 is co-recruited to a subset of IFN-γ-induced, STAT1-bound regulatory elements. While IFN-γ directly activates STAT3, our results reveal that its contribution to IFN-γ-induced gene expression is limited. Instead, our data indicate that STAT1-STAT3 heterodimers exert a more prominent function in mixed cytokine environments. These findings uncover STAT3 as an unconventional player in macrophage IFN-γ signaling, underscoring the complex and context-dependent nature of cytokine signaling networks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam Cardiovascular Sciences Institute, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.
- Department of Internal Medicine I, Aachen-Maastricht Institute for Cardio-Renal Disease (AMICARE), and Institute for Molecular Cardiovascular Research (IMCAR), University Hospital Aachen, RWTH Aachen University, Aachen,…
- Division Pharmacology, Department of Pharmacology, Physiology and Microbiology, Karl Landsteiner University of Health Sciences, Krems, Austria.
- Department of Medical Biochemistry, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam Cardiovascular Sciences Institute, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands. Electronic address: m…
Förderung
- European Research Council
- Corona Foundation
- Netherlands Organisation for Health Research and Development
- Deutsche Forschungsgemeinschaft
- European Commission
Zitieren
APA
Botman, M., Huisman, J. M. A., Drakaki, A., Maas, S. L., Witalisz-Siepracka, A., Stoiber, D., van der Vorst, E. P. C., Siebeler, R., & Hoeksema, M. A. (2026). Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling. Cell Reports. https://doi.org/10.1016/j.celrep.2026.116985
Vancouver
Botman M, Huisman JMA, Drakaki A, Maas SL, Witalisz-Siepracka A, Stoiber D, et al. Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling. Cell Reports. 2026. doi:10.1016/j.celrep.2026.116985
BibTeX
@article{Botman2026,
author = {Botman, Mees and Huisman, Josje M A and Drakaki, Alexandra and Maas, Sanne L and Witalisz-Siepracka, Agnieszka and Stoiber, Dagmar and van der Vorst, Emiel P C and Siebeler, Ricky and Hoeksema, Marten A},
title = {Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.116985}
}
EUVIMED